BOLT
Bolt Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
3.74 / 10
Netural
With a fund flow rating of 7.48/10, the stock shows robust fund flow characteristics. Supportive momentum from Large trends is partially offset by concerning overall, block, Small, Medium, and Extra-large patterns, pointing to positive capital flow trajectory. Analyst consensus points to overwhelmingly bullish analyst consensus with strong conviction. Distribution analysis: Strong Buy(100.0%) among 1 research opinions, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-20
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of BOLT?
- BOLT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.74/10 (Netural).
